Pixilab
Home › Companies › Biotechnology, Life Science, Therapeutics › Leyden Labs

Leyden Labs

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Leyden Labs operates in biotechnology, life science, therapeutics based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2020.

As a business in biotechnology, life science, therapeutics, Leyden Labs is listed here with the public details available about it.

Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).

Directory data places it at the Series_B stage.

Its team size is recorded as c_00051_00100 employees.

Total disclosed funding stands at about $187.1M.

SectorBiotechnology, Life Science, Therapeutics
HeadquartersEuropean Union (EU), Europe, Middle East, and Africa (EMEA)
CountryUnited States
Founded2020
Employeesc_00051_00100
Stageseries_b
Total funding$187,105,929

Website: www.leydenlabs.com

Browse related

More Biotechnology, Life Science, Therapeutics companies Companies in United States Companies founded in 2020
Full contact details are available to registered Pixilab members.
Create a free account